Methods for treating myositis using fcrn antagonists

TW202631195APending Publication Date: 2026-08-01ARGENX BVBA(BE)
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-11-19
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001071200_001
    Figure TWG2TA001071200_001
  • Figure TWG2TA001071200_002
    Figure TWG2TA001071200_002
  • Figure TWG2TA001071200_003
    Figure TWG2TA001071200_003
Patent Text Reader

Abstract

Provided herein are methods of treating myositis using an effective amount of a human neonatal Fc receptor (FcRn) antagonist. FcRn antagonists for use in the treatment of myositis and for use in the manufacture of a medicament for the treatment of myositis are also provided herein.
Need to check novelty before this filing date? Find Prior Art